We provide direct evidence that ATLL tumor cells display low global 5-hmc level as compared to normal T cells and that levels of 5-hmc and TET2 further distinguish tumor T cells from acute patients from those of chronic patients. The gene discussed is TET2; the disease is adult T-cell leukemia/lymphoma.